Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2005 Aug;76(8):1109–1114. doi: 10.1136/jnnp.2004.048140

Age associated axonal features in HNPP with 17p11.2 deletion in Japan

H Koike 1, M Hirayama 1, M Yamamoto 1, H Ito 1, N Hattori 1, F Umehara 1, K Arimura 1, S Ikeda 1, Y Ando 1, M Nakazato 1, R Kaji 1, K Hayasaka 1, M Nakagawa 1, S Sakoda 1, K Matsumura 1, O Onodera 1, M Baba 1, H Yasuda 1, T Saito 1, J Kira 1, K Nakashima 1, N Oka 1, G Sobue 1
PMCID: PMC1739771  PMID: 16024889

Abstract

Objective: To clarify age related changes in the clinicopathological features of hereditary neuropathy with liability to pressure palsy (HNPP) in Japanese patients with deletion of 17p11.2, particularly concerning axonal abnormalities.

Methods: Forty eight proband patients from 48 HNPP families were assessed as to clinical, electrophysiological, and histopathological features, including age associated changes beyond those in controls.

Results: Motor conduction studies showed age associated deterioration of compound muscle action potentials in nerves vulnerable to repetitive compression (median, ulnar, and peroneal nerves), but not in others such as the tibial nerve. Sensory conduction studies revealed more profound reduction of action potentials than motor studies with little age related change. Large myelinated fibre loss was seen in the sural nerve irrespective of age at examination.

Conclusions: Irreversible axonal damage may occur at entrapment sites in motor nerves in HNPP patients, progressing with aging. Sensory nerves may show more profound axonal abnormality, but without age association. The electrophysiological features of HNPP are presumed to be a mixture of abnormalities occurring from early in life and acquired features caused by repetitive insults at entrapment sites. Unlike Charcot-Marie-Tooth disease type 1A, age associated axonal damage may not occur unless the nerves are subjected to compression.

Full Text

The Full Text of this article is available as a PDF (102.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson P. B., Yuen E., Parko K., So Y. T. Electrodiagnostic features of hereditary neuropathy with liability to pressure palsies. Neurology. 2000 Jan 11;54(1):40–44. doi: 10.1212/wnl.54.1.40. [DOI] [PubMed] [Google Scholar]
  2. Behse F., Buchthal F., Carlsen F., Knappeis G. G. Hereditary neuropathy with liability to pressure palsies. Electrophysiological and histopathological aspects. Brain. 1972;95(4):777–794. doi: 10.1093/brain/95.4.777. [DOI] [PubMed] [Google Scholar]
  3. Chance P. F., Alderson M. K., Leppig K. A., Lensch M. W., Matsunami N., Smith B., Swanson P. D., Odelberg S. J., Disteche C. M., Bird T. D. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell. 1993 Jan 15;72(1):143–151. doi: 10.1016/0092-8674(93)90058-x. [DOI] [PubMed] [Google Scholar]
  4. DAVIES D. M. Recurrent peripheral nerve palsies in a family. Lancet. 1954 Aug 7;267(6832):266–268. doi: 10.1016/s0140-6736(54)90193-2. [DOI] [PubMed] [Google Scholar]
  5. Dyck P. J., Karnes J. L., Lambert E. H. Longitudinal study of neuropathic deficits and nerve conduction abnormalities in hereditary motor and sensory neuropathy type 1. Neurology. 1989 Oct;39(10):1302–1308. doi: 10.1212/wnl.39.10.1302. [DOI] [PubMed] [Google Scholar]
  6. EARL C. J., FULLERTON P. M., WAKEFIELD G. S., SCHUTTA H. S. HEREDITARY NEUROPATHY, WITH LIABILITY TO PRESSURE PALSIES; A CLINICAL AND ELECTROPHYSIOLOGICAL STUDY OF FOUR FAMILIES. Q J Med. 1964 Oct;33:481–498. [PubMed] [Google Scholar]
  7. GILLIATT R. W., MELVILLE I. D., VELATE A. S., WILLISON R. G. A STUDY OF NORMAL NERVE ACTION POTENTIALS USING AN AVERAGING TECHNIQUE (BARRIER GRID STORAGE TUBE). J Neurol Neurosurg Psychiatry. 1965 Jun;28:191–200. doi: 10.1136/jnnp.28.3.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gouider R., LeGuern E., Gugenheim M., Tardieu S., Maisonobe T., Léger J. M., Vallat J. M., Agid Y., Bouche P., Brice A. Clinical, electrophysiologic, and molecular correlations in 13 families with hereditary neuropathy with liability to pressure palsies and a chromosome 17p11.2 deletion. Neurology. 1995 Nov;45(11):2018–2023. doi: 10.1212/wnl.45.11.2018. [DOI] [PubMed] [Google Scholar]
  9. Hattori N., Ichimura M., Nagamatsu M., Li M., Yamamoto K., Kumazawa K., Mitsuma T., Sobue G. Clinicopathological features of Churg-Strauss syndrome-associated neuropathy. Brain. 1999 Mar;122(Pt 3):427–439. doi: 10.1093/brain/122.3.427. [DOI] [PubMed] [Google Scholar]
  10. Hattori Naoki, Yamamoto Masahiko, Yoshihara Tsuyoshi, Koike Haruki, Nakagawa Masanori, Yoshikawa Hiroo, Ohnishi Akio, Hayasaka Kiyoshi, Onodera Osamu, Baba Masayuki. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients. Brain. 2003 Jan;126(Pt 1):134–151. doi: 10.1093/brain/awg012. [DOI] [PubMed] [Google Scholar]
  11. Kimura J., Machida M., Ishida T., Yamada T., Rodnitzky R. L., Kudo Y., Suzuki S. Relation between size of compound sensory or muscle action potentials, and length of nerve segment. Neurology. 1986 May;36(5):647–652. doi: 10.1212/wnl.36.5.647. [DOI] [PubMed] [Google Scholar]
  12. Kimura J. The carpal tunnel syndrome: localization of conduction abnormalities within the distal segment of the median nerve. Brain. 1979 Sep;102(3):619–635. doi: 10.1093/brain/102.3.619. [DOI] [PubMed] [Google Scholar]
  13. Kiyosawa H., Lensch M. W., Chance P. F. Analysis of the CMT1A-REP repeat: mapping crossover breakpoints in CMT1A and HNPP. Hum Mol Genet. 1995 Dec;4(12):2327–2334. doi: 10.1093/hmg/4.12.2327. [DOI] [PubMed] [Google Scholar]
  14. Koike Haruki, Iijima Masahiro, Sugiura Makoto, Mori Keiko, Hattori Naoki, Ito Hiroki, Hirayama Masaaki, Sobue Gen. Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy. Ann Neurol. 2003 Jul;54(1):19–29. doi: 10.1002/ana.10550. [DOI] [PubMed] [Google Scholar]
  15. Koike Haruki, Misu Ken-ichiro, Ikeda Shu-ichi, Ando Yukio, Nakazato Masamitsu, Ando Eiko, Yamamoto Masahiko, Hattori Naoki, Sobue Gen, Study Group for Hereditary Neuropathy in Japan Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs late-onset form. Arch Neurol. 2002 Nov;59(11):1771–1776. doi: 10.1001/archneur.59.11.1771. [DOI] [PubMed] [Google Scholar]
  16. Korn-Lubetzki Isabelle, Argov Zohar, Raas-Rothschild Annick, Wirguin Itzchak, Steiner Israel. Family with inflammatory demyelinating polyneuropathy and the HNPP 17p12 deletion. Am J Med Genet. 2002 Dec 1;113(3):275–278. doi: 10.1002/ajmg.10725. [DOI] [PubMed] [Google Scholar]
  17. Krajewski K. M., Lewis R. A., Fuerst D. R., Turansky C., Hinderer S. R., Garbern J., Kamholz J., Shy M. E. Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain. 2000 Jul;123(Pt 7):1516–1527. doi: 10.1093/brain/123.7.1516. [DOI] [PubMed] [Google Scholar]
  18. Li Jun, Krajewski Karen, Shy Michael E., Lewis Richard A. Hereditary neuropathy with liability to pressure palsy: the electrophysiology fits the name. Neurology. 2002 Jun 25;58(12):1769–1773. doi: 10.1212/wnl.58.12.1769. [DOI] [PubMed] [Google Scholar]
  19. Lupski J. R., de Oca-Luna R. M., Slaugenhaupt S., Pentao L., Guzzetta V., Trask B. J., Saucedo-Cardenas O., Barker D. F., Killian J. M., Garcia C. A. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell. 1991 Jul 26;66(2):219–232. doi: 10.1016/0092-8674(91)90613-4. [DOI] [PubMed] [Google Scholar]
  20. Mariman E. C., Gabreëls-Festen A. A., van Beersum S. E., Valentijn L. J., Baas F., Bolhuis P. A., Jongen P. J., Ropers H. H., Gabreëls F. J. Prevalence of the 1.5-Mb 17p deletion in families with hereditary neuropathy with liability to pressure palsies. Ann Neurol. 1994 Oct;36(4):650–655. doi: 10.1002/ana.410360415. [DOI] [PubMed] [Google Scholar]
  21. Misu K. i., Hattori N., Nagamatsu M., Ikeda S. i., Ando Y., Nakazato M., Takei Y. i., Hanyu N., Usui Y., Tanaka F. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features. Brain. 1999 Oct;122(Pt 10):1951–1962. doi: 10.1093/brain/122.10.1951. [DOI] [PubMed] [Google Scholar]
  22. Mouton P., Tardieu S., Gouider R., Birouk N., Maisonobe T., Dubourg O., Brice A., LeGuern E., Bouche P. Spectrum of clinical and electrophysiologic features in HNPP patients with the 17p11.2 deletion. Neurology. 1999 Apr 22;52(7):1440–1446. doi: 10.1212/wnl.52.7.1440. [DOI] [PubMed] [Google Scholar]
  23. Oda K., Miura H., Shibasaki H., Endo C., Kakigi R., Kuroda Y., Tanaka K. Hereditary pressure-sensitive neuropathy: demonstration of "tomacula" in motor nerve fibers. J Neurol Sci. 1990 Sep;98(2-3):139–148. doi: 10.1016/0022-510x(90)90254-k. [DOI] [PubMed] [Google Scholar]
  24. Pareyson D., Scaioli V., Taroni F., Botti S., Lorenzetti D., Solari A., Ciano C., Sghirlanzoni A. Phenotypic heterogeneity in hereditary neuropathy with liability to pressure palsies associated with chromosome 17p11.2-12 deletion. Neurology. 1996 Apr;46(4):1133–1137. doi: 10.1212/wnl.46.4.1133. [DOI] [PubMed] [Google Scholar]
  25. Rhee E. K., England J. D., Sumner A. J. A computer simulation of conduction block: effects produced by actual block versus interphase cancellation. Ann Neurol. 1990 Aug;28(2):146–156. doi: 10.1002/ana.410280206. [DOI] [PubMed] [Google Scholar]
  26. Sahenk Z., Chen L., Mendell J. R. Effects of PMP22 duplication and deletions on the axonal cytoskeleton. Ann Neurol. 1999 Jan;45(1):16–24. doi: 10.1002/1531-8249(199901)45:1<16::aid-art5>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  27. Sancho S., Young P., Suter U. Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A. Brain. 2001 Nov;124(Pt 11):2177–2187. doi: 10.1093/brain/124.11.2177. [DOI] [PubMed] [Google Scholar]
  28. Sander S., Ouvrier R. A., McLeod J. G., Nicholson G. A., Pollard J. D. Clinical syndromes associated with tomacula or myelin swellings in sural nerve biopsies. J Neurol Neurosurg Psychiatry. 2000 Apr;68(4):483–488. doi: 10.1136/jnnp.68.4.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sobue G., Hashizume Y., Mukai E., Hirayama M., Mitsuma T., Takahashi A. X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain. 1989 Feb;112(Pt 1):209–232. doi: 10.1093/brain/112.1.209. [DOI] [PubMed] [Google Scholar]
  30. Sobue G., Yasuda T., Mitsuma T., Ross A. H., Pleasure D. Expression of nerve growth factor receptor in human peripheral neuropathies. Ann Neurol. 1988 Jul;24(1):64–72. doi: 10.1002/ana.410240112. [DOI] [PubMed] [Google Scholar]
  31. Tyson J., Malcolm S., Thomas P. K., Harding A. E. Deletions of chromosome 17p11.2 in multifocal neuropathies. Ann Neurol. 1996 Feb;39(2):180–186. doi: 10.1002/ana.410390207. [DOI] [PubMed] [Google Scholar]
  32. Yamamoto M., Keller M. P., Yasuda T., Hayasaka K., Ohnishi A., Yoshikawa H., Yanagihara T., Mitsuma T., Chance P. F., Sobue G. Clustering of CMT1A duplication breakpoints in a 700 bp interval of the CMT1A-REP repeat. Hum Mutat. 1998;11(2):109–113. doi: 10.1002/(SICI)1098-1004(1998)11:2<109::AID-HUMU2>3.0.CO;2-E. [DOI] [PubMed] [Google Scholar]
  33. Yamamoto M., Yasuda T., Hayasaka K., Ohnishi A., Yoshikawa H., Yanagihara T., Ikegami T., Yamamoto T., Ohashi H., Nishimura T. Locations of crossover breakpoints within the CMT1A-REP repeat in Japanese patients with CMT1A and HNPP. Hum Genet. 1997 Feb;99(2):151–154. doi: 10.1007/s004390050330. [DOI] [PubMed] [Google Scholar]
  34. de Waegh S. M., Lee V. M., Brady S. T. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell. 1992 Feb 7;68(3):451–463. doi: 10.1016/0092-8674(92)90183-d. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES